DUFFY ERIN (Chief Scientific Officer) purchased 4K shares of MELINTA THERAPEUTICS, INC. /NEW/ on the open market
Open‑market purchase worth $20.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/31/2018ACC: 0000899243-18-014564
Officer· Chief Scientific Officer
Since Jun 2018
+4K
Net shares
Net buyer
$20.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4K
Price / share
$5.00
Trade value
$20K
% of position
New position
5/29/2018
0.00→4K
Total
Net shares
+4K
Net value
$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2018 | P · Purchase | +4K | $5.00 | $20K | New position | 0.00 | 4K |
| Total | +4K | $20K | ||||||
Derivative Transactions0
No derivative transactions reported